Research Explainer Series:

Prospective Outcomes Studies

Prospective outcomes studies play a crucial role in understanding the various potential outcomes and effects of different treatments or interventions on groups of individuals. Unlike some other forms of research, these studies offer in-depth insights by observing participants over a period of time rather than at a single point.

Cross-sectional research design, for instance, is a type of observational study that examines a snapshot or cross-section of a population at a particular point in time. For example, the prevalence of a disease in a certain population may be determined by examining individuals at that particular moment. It's comparable to taking a snapshot; the image captures the current conditions rather than the changes over time.

Cross-sectional studies provide researchers with valuable data but with certain limitations: one often cited limitation is that due to the inherent nature of cross-sectional studies, they do not facilitate the establishment of cause-effect relationships, they only identify correlations.

Longitudinal research design, in contrast, goes beyond a single point observation by studying participants over an extended period. By tracking changes and developments over time, this method provides in-depth understanding and valuable insights. This type of studies involve repeated observations of the same variables over long periods of time – sometimes lasting decades. These methods offer an effective and comprehensive approach for gaining profound knowledge and grasping the evolution of trends.

There are two major types of design: prospective and retrospective. The former refers to studies which involve observing outcomes of a population group under study in real time, while the latter refers to studies which scrutinize the distinct outcomes after they have taken place (i.e. from using data that was collected in the past).

The term "prospective" refers to the future-oriented nature of these studies. Researchers decide ahead of time what outcomes they will measure, then begin the study and track these outcomes over time. This can allow for a deeper understanding of cause-effect relationships as the outcomes can be tracked and linked to different variables within the study.

In contrast, for "retrospective" studies, while the research question and methods are determined before starting the study (as in prospective designs), the difference lies in the data itself – researchers investigate and analyze past data.

To delineate this concept further, let's examine a prospective study example to shed more light. Take, for instance, a study investigating the correlation between smoking and lung cancer. In this case, the researchers would first identify individuals who smoke and do not smoke, then follow them over several years to study if smokers develop lung cancer more frequently compared to non-smokers.

On the other hand, the retrospective study design, as the name suggests, looks backward in time. This method relies on existing data from past events to draw conclusions. An example of a retrospective study would be investigating historical data of patients who had developed lung cancer and then determining the percentage of these patients who were smokers, enabling researchers to establish a possible link.

To recap: understanding all these different terminologies and concepts can help provide clarity when conducting or interpreting different kinds of research studies. Whether the study is prospective, retrospective, cross-sectional or longitudinal, each has its own strengths and drawbacks that must be carefully considered.

Types Of Prospective Studies

A prospective study, also known as a forward-looking study, is primarily a long-term investigation that focuses on gathering data from the present to the future, usually concerning a particular occurrence or event related to a group of subjects. The types of prospective studies are varied, yet they largely fall into categories like cohort studies and clinical trials.

This rigorous research method takes a forward-looking approach, beginning in the present and proceeding with participants into the future. Contrasted against retrospective studies, which analyze pre-existing data or historical medical records, these forward-looking studies yield particularly compelling insights into the cause-and-effect relationships between risk factors and health outcomes.

One intriguing type of prospective study is the combined retrospective and prospective study. These amalgamation studies take a hybrid approach, deriving benefits from both retrospective and prospective types. It utilizes data from past records and concurrently collects forward-looking data. This kind of study, due to its dual approach, can offer a richer dataset and a more comprehensive overview of the incidence and progression of a condition.

For instance, a prospective observational study example might involve researchers studying a broad cross-section of the population over several years to measure the impact of a specific lifestyle factor, like diet or exercise, on the occurrence of heart disease. This kind of study design allows insights to be drawn on the relationship between the chosen lifestyle factor and heart disease within the specific population.

An essential feature of all these types of prospective studies is a distinctive prospective study design. This type of design involves identifying a population of interest, clarifying the hypotheses to be tested, defining the exposure and outcome measures, and establishing a suitable strategy for data collection and analysis. Prospective study designs aim to predict an outcome based on observed variables over time - lending credibility and directness to conclusions drawn from such studies.

Examples of Prospective Studies

For more examples, check out Folia Health’s publication library.

 

 

Reflect the true value of your therapy with

 
 

Patient-Centered Research Solutions for Life Sciences

 
 

Chroma provides the most granular measurement of patients’ longitudinal experiences & outcomes, captured where life happens:

 
 

Tracking data from real user “Emily” (renamed)

Without Folia, our user Emily would have generated clinical data on only 5 days in 2019.

With Folia, Emily generated a structured dataset that captured what happens between clinic visits, including:

  • Flares/Acute events, and resolutions

  • Non-standard symptoms

  • Treatment use, or reasons for non-use

With decreased recall bias and the ability to capture only the outcomes that matter to her.

 
 

Uniquely designed to maximize flexibility
and create phenomenal participant experiences:

A disease-agnostic platform supporting 500+ conditions:

Patients and caregivers use Folia Health to track daily experiences across:

  • Autoimmune conditions

  • Neurological, psychiatric and behavioral conditions

  • Genetic and rare conditions

  • Cancer and hematology

  • Chronic and more

Sponsors provide day-to-day value to participants:

  • Users e-consent into prospective outcomes studies, and get compensated for participation.

  • Study data is immediately available for participant use with their care team.

  • And once the study is complete, patients continue to track on Folia - for free, for life.

 

A suite of patient-driven outcomes solutions built for life sciences,
from early clinical development to therapy commercialization:

 
 
 

Natural History

 
 

Burden

 
 

Impact

 
 

How Chroma works

Comprehensive, end-to-end research solution for complex, heterogeneous conditions:

  • Dedicated research and analysis team

  • Protocol design & approval

  • Multi-channel recruitment, e-consent, enrollment

  • Validated ePRO deployment that complements HROs

  • Data stewardship & hosting

  • Linkage to EMR, claims, wearables, and registry data

  • Data analysis and reporting

  • Thought partnership for scientific communications and publications

 

Customer Perspectives:

 

My programs often struggle with the fact that traditional clinical endpoints do not demonstrate the full value of the therapy, and we experience a disconnect about endpoints needed for Approval vs. for Reimbursement.

Vice President, HEOR (Neurology Biotech)

This gives you insight that you don’t get from PROs and does not rely on long recall period. To me, that is the interesting nuance.


Executive Director, WW HEOR RWD (Top 10 Pharma)

 
 
 

Why Life Sciences Innovators Choose Folia

Solve common RWD dataset challenges:

  • Identify, characterize, and measure change in currently undetected flare events 

  • Measure disease heterogeneity and discover phenotypes that drive how patients do on therapy

  • Understand treatment use, including “Why not?” reasons and missing doses/switching medications

Patient-driven, high fidelity, and high value insights:

  • Discover the full scope of patient priorities & how your therapy impacts them

  • Reduce responder burden with questions that are relevant to each participant’s journey

  • Drive value to the patient with built-in patient data return

 

Featured Blog Posts